SEGALL BRYANT & HAMILL, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$7,296,000
-50.6%
65,691
-47.2%
0.07%
-56.1%
Q4 2020$14,775,000
+27.7%
124,380
-6.2%
0.16%
+4.5%
Q3 2020$11,572,000
+194.2%
132,658
+201.9%
0.16%
+137.9%
Q2 2020$3,934,000
+425.2%
43,939
+484.6%
0.07%
+340.0%
Q1 2020$749,000
-78.2%
7,516
-80.4%
0.02%
-71.2%
Q2 2018$3,441,000
-29.2%
38,368
-42.2%
0.05%
-54.0%
Q1 2018$4,860,000
-55.0%
66,435
-64.3%
0.11%
-52.5%
Q4 2017$10,810,000
+21.3%
186,114
-6.3%
0.24%
+15.0%
Q3 2017$8,915,000
+11.5%
198,690
-1.8%
0.21%
+10.1%
Q2 2017$7,994,000
+42.1%
202,420
+46.0%
0.19%
+38.2%
Q1 2017$5,626,000
+17.8%
138,672
+16.8%
0.14%
+13.3%
Q4 2016$4,774,000
+12.4%
118,764
+1.2%
0.12%
+10.1%
Q3 2016$4,248,000
+117.3%
117,317
+73.9%
0.11%
+109.6%
Q2 2016$1,955,000
+10.0%
67,452
+32.8%
0.05%
+18.2%
Q1 2016$1,777,000
-50.7%
50,807
-41.7%
0.04%
-45.7%
Q2 2015$3,603,000
-6.8%
87,108
+1.2%
0.08%
-6.9%
Q1 2015$3,867,000
+19.8%
86,093
-0.2%
0.09%
+19.2%
Q4 2014$3,228,000
+35.1%
86,268
+26.1%
0.07%
+32.7%
Q3 2014$2,389,000
+387.6%
68,403
+392.4%
0.06%
+358.3%
Q2 2014$490,000
-82.1%
13,893
-83.4%
0.01%
-63.6%
Q1 2014$2,732,000
-39.9%
83,808
-22.3%
0.03%
-37.7%
Q4 2013$4,546,000
+98.1%
107,884
+87.5%
0.05%
-7.0%
Q3 2013$2,295,000
-2.3%
57,551
+1.3%
0.06%
-8.1%
Q2 2013$2,348,000
-7.0%
56,792
-6.3%
0.06%
-7.5%
Q1 2013$2,525,00060,6040.07%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders